Oxaliplatin injection ceiling price cut to ₹2,285.84
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals of the Ministry of Chemicals and Fertilizers, issued Order S.O. 6001(E) dated November 2, 2026, published the same day in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5769.
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals of the Ministry of Chemicals and Fertilizers, issued Order S.O. 6001(E) dated November 2, 2026, published the same day in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5769. It carries out the directions of a review order of the Department of Pharmaceuticals under paragraph 31 of the Drugs (Prices Control) Order, 2013 (DPCO, 2013), No. 31015/39/2023-Pricing(E-23351) dated March 30, 2026. NPPA used the powers in paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the DPCO, 2013, read with S.O. 1394(E) of May 30, 2013 and S.O. 5249(E) of November 11, 2022.
The order fixes the ceiling price of Oxaliplatin, "Injection 5 mg/mL in 10 mL vial", at ₹2,285.84 per vial, exclusive of Goods and Services Tax (GST). The figure includes the wholesale price index (WPI) impact of 0.64956% for the year 2026. The table gives ₹2,287.59 as the ceiling price under NLEM, 2022. The order supersedes S.O. 1575(E) of March 25, 2026, at serial number 562.
Manufacturers selling the branded or generic version above the ceiling price plus applicable GST must cut their prices to no more than ₹2,285.84 plus applicable GST. Those already below it keep their existing MRP under paragraph 13(2). GST may be added only if it has actually been paid or is payable. Each manufacturer works out the price of a pack under paragraph 11 and must issue a price list in Form V to NPPA through IPDMS, with a copy to the State Drug Controller and dealers, and retailers and dealers must display it. An existing maker of the formulation at the listed dosage or strength that launches a "new drug" under paragraph 2(1)(u) must apply to NPPA for prior price approval in Form I. Quarterly returns go in Form III, and a maker stopping production must tell NPPA in Form IV at least six months before. A manufacturer that does not comply must deposit the overcharged amount with interest under the DPCO, 2013 read with the Essential Commodities Act, 1955.
The order does not give the review order's reasons or name the company that sought the review, and it states no date from which the new price applies. The minutes of NPPA's 153rd meeting under the DPCO, 2013, held on October 29, 2026, record that M/s Dr. Reddy's Laboratories Ltd. had sought a review of NPPA's notification S.O. 194(E) of January 11, 2023 because its brand "Dacotin RTU 50 mg/10 ml vial" had not been considered in calculating the ceiling price, and that NPPA recalculated the price after adding five more SKUs. The order is signed by Bhiva Ram Yadav, Assistant Director, under PN/285/153/2026/F F. No. 8(153)/2026/D.P./NPPA-Div.-II.
- Issued by
- National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
- Document
- Order S.O. 6001(E)
- Dated
- November 2, 2026
- Published
- Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5769, November 2, 2026
- Formulation
- Oxaliplatin, Injection 5 mg/mL in 10 mL vial, per 1 vial
- Previous ceiling price
- ₹2,287.59 (ceiling price under NLEM, 2022)
- Revised ceiling price
- ₹2,285.84, excluding GST, including WPI of 0.64956% for 2026
- Review order
- Department of Pharmaceuticals, No. 31015/39/2023-Pricing(E-23351), March 30, 2026, under paragraph 31 of the DPCO, 2013
- Supersedes
- S.O. 1575(E) of March 25, 2026, serial number 562
- Takes effect
- The order states no date; Form V is to be issued from the date of notification
- Signed by
- Bhiva Ram Yadav, Assistant Director
The revised ceiling price
| Medicine | Dosage form and strength | Unit | Ceiling price under NLEM, 2022 (₹) | Revised ceiling price, with WPI of 0.64956% (₹) | Review order | Superseded S.O. |
|---|---|---|---|---|---|---|
| Oxaliplatin | Injection 5 mg/mL in 10 mL vial | 1 Vial | 2287.59 | 2285.84 | 31015/39/2023-Pricing(E-23351) dated 30.03.2026 | 1575(E) dated 25.03.2026 (Sl. No. 562) |
The order (PDF, 613 KB)
Source: Gazette of India, CG-DL-E-03112026-277613.
Checked against the official copy on November 7, 2026.